XTL Biopharmaceuticals Ltd.
XTLB | NASDAQ
$2.35
-$0.03 (-1.26%)
At close: Sep 22, 2026, 3:59 PM ET
$2.20
-$0.15 (-6.38%)
After-hours:
Sep 22, 2026, 4:10 PM ET
Fiscal Quarter Period Ending | Q4 2025 Dec 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 | Q4 2020 Dec 30, 2020 | Q3 2020 Sep 29, 2020 | Q2 2020 Jun 29, 2020 | Q1 2020 Mar 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 76K | 371K | 820K | 594K | 1.07M | 1.4M | 1.46M | 1.59M | 1.9M | 2.09M | 2.23M | 2.35M | 2.79M | 2.97M | 3.01M | 2.92M | 3.39M | 3.63M | 3.75M | 4.03M | 4.26M |
Short-Term Investments | 68K | 772K | 900K | 992K | 1.27M | 605K | 749K | 794K | 972K | 1.63M | 2.16M | 2.81M | n/a | 3.16M | n/a | 3.38M | n/a | 2.41M | n/a | n/a | n/a |
Long-Term Investments | n/a | 14K | n/a | n/a | n/a | -604.4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | 604.4K | n/a | n/a | n/a | n/a | n/a | n/a | 381K | n/a | 382K | n/a | 382K | n/a | 382K | 381K | 382K |
Receivables | n/a | 99K | 140K | 304K | 150K | 29K | n/a | n/a | n/a | 71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 22K | 47K | n/a | n/a | n/a | -18K | n/a | n/a | n/a | -57K | n/a | n/a | 3.45M | 16K | 3.46M | n/a | 3.54M | 13K | 2.08M | 2.38M | 2.63M |
Total Current Assets | 166K | 1.34M | 1.99M | 2.02M | 2.55M | 2.05M | 2.28M | 2.5M | 2.94M | 3.81M | 4.52M | 5.38M | 6.24M | 6.24M | 6.47M | 6.57M | 6.93M | 6.12M | 5.83M | 6.41M | 6.89M |
Property-Plant & Equipment | n/a | 187K | 217K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | 1K | n/a | 2K | n/a | 2K | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | 7.01M | 7.08M | 380K | 380K | 380K | 380K | 380K | 380K | 380K | 380K | 380K | n/a | 380K | n/a | 380K | n/a | 380K | n/a | n/a | n/a |
Total Long-Term Assets | n/a | 7.21M | 7.29M | 380K | 380K | 380K | 380K | 380K | 380K | 380K | 380K | 381K | 381K | 381K | 382K | 382K | 382K | 382K | 382K | 381K | 382K |
Total Assets | 166K | 8.55M | 9.28M | 2.4M | 2.93M | 2.43M | 2.66M | 2.88M | 3.32M | 4.19M | 4.9M | 5.76M | 6.62M | 6.62M | 6.86M | 6.95M | 7.31M | 6.5M | 6.21M | 6.79M | 7.27M |
Account Payables | 20K | 196K | 554K | 165K | 223K | 1K | 162K | 163K | 241K | 2K | 153K | 172K | n/a | 2K | 185K | 258K | n/a | 2K | n/a | n/a | n/a |
Deferred Revenue | n/a | 18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 269K | 138K | 168K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 2K | 1.33M | 1.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 420K | 2.21M | 2.47M | 165K | 223K | 206K | 162K | 163K | 241K | 187K | 153K | 172K | 260K | 231K | 185K | 258K | 251K | 254K | 182K | 194K | 244K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 689K | 765K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 22K | 517K | 1.05M | 3.59M | 3.41M | 2.69M | 2.64M | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | 908K | 1.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 22K | 517K | 1.05M | 3.59M | 3.41M | 2.69M | 2.64M | n/a | n/a | n/a |
Total Liabilities | 420K | 3.12M | 3.56M | 165K | 223K | 206K | 162K | 163K | 241K | 187K | 153K | 194K | 777K | 1.29M | 3.78M | 3.67M | 2.94M | 254K | 182K | 194K | 244K |
Total Debt | 269K | 138K | 168K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Book Value | -254K | 5.44M | 5.72M | 2.23M | 2.71M | 2.22M | 2.5M | 2.72M | 3.08M | 4M | 4.74M | 5.56M | 5.84M | 5.33M | 3.08M | 3.28M | 4.37M | 6.25M | 6.03M | 6.6M | 7.03M |
Book Value Per Share | -0.58 | 15.96 | 16.79 | 6.56 | 7.94 | 6.52 | 7.34 | 7.98 | 9.05 | 11.74 | 13.93 | 16.33 | 16.21 | 15.86 | 9.33 | 9.96 | 13.59 | 19.44 | 18.76 | 20.52 | 21.86 |
Common Stock | 25.14M | 23.14M | 23.14M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 5.84M | 14.12M | 3.08M | 13.6M | 4.37M | 13.18M | 6.03M | 6.6M | 7.03M |
Retained Earnings | -165.63M | -159.01M | -158.77M | -158.23M | -157.76M | -158.25M | -157.97M | -157.75M | -157.39M | -156.47M | -155.72M | -154.9M | n/a | -155.13M | n/a | -156.45M | n/a | -154.66M | n/a | n/a | n/a |
Comprehensive Income | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 20K | n/a | 20K | n/a | 20K | n/a | 20K | n/a | n/a | n/a |
Shareholders Equity | -254K | 5.44M | 5.72M | 2.23M | 2.71M | 2.22M | 2.5M | 2.72M | 3.08M | 4M | 4.74M | 5.56M | 5.84M | 5.33M | 3.08M | 3.28M | 4.37M | 6.25M | 6.03M | 6.6M | 7.03M |
Total Investments | 68K | 786K | 900K | 992K | 1.27M | 605 | 749K | 794K | 972K | 1.63M | 2.16M | 2.81M | n/a | 3.16M | n/a | 3.38M | n/a | 2.41M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove XTLB